Throughout this year, we’ve had the pleasure of crossing paths with many of you at diverse locations around the world – from San Francisco and Boston, to the nation’s capital and the Big Apple, to Montreal and Riyadh. We shared our work at more than two dozen meetings, conferences, and events, and it’s been truly gratifying to see our community actively engaged in our work on a global level. 

In 2023, CTTI has redefined possibilities around some of the clinical trials enterprise’s most pressing challenges and made strides toward creating a more effective and efficient research process. We’re proud to share the results of those efforts in our 2023 CTTI Annual Report. 

As we usher in a new year with CTTI’s next generation of leadership, our strategy is to build on CTTI’s key strengths by offering new engagement and implementation opportunities with our members that are focused, flexible, and poised for impactful change, including: 

• Last Mile Implementation: CTTI is well-known for launching products and recommendations to improve the quality and efficiency of clinical trials. Yet, we recognize that more is needed to drive sustainable and scalable change. Therefore, we will test innovative approaches to make CTTI recommendations easier to implement in a range of settings, including our website. 
• Engagement Diversification: CTTI’s flagship multi-year project archetype is important and we appreciate that in-depth learning and meaningful multi-stakeholder consensus takes time. We are eager to forge different modes of engaging, including more dynamic conversations with members and with the FDA. With the increased accessibility of powerful AI tools, research is changing rapidly, presenting interesting opportunities to learn together by convening in new and interesting ways. 
• Dynamic Collaborations: There’s growing attention from private and public sectors as the U.S. government (including OSTP, NIH, ARPA-H and the FDA) intensifies its focus on clinical trials modernization and readiness. We’re delighted by the new and growing initiatives from digital platform companies to bring the research experience closer to patients wherever they are. CTTI has a crucial role to play, and we’ll continue to partner with our members, related efforts, and organizations around the world to harness these moments for impact.  

To our CTTI community, we thank you. While we all come from different parts of this complex enterprise, our collective culture is strong and our commitment steadfast. As our organization transitions from one leader to the next, we will carry CTTI’s legacy forward together by building on the work of leaders and members, past and present, to shape the future of clinical trials that we all want for ourselves and our loved ones.  

As we set our sights on 2024 and beyond, look to CTTI to pick up the pace of innovation and transformation in respect to our mission. We wish you a wonderful holiday season and a prosperous new year!